Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
Closed Posted
- Opportunity number
- RFA-AI-27-004
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Independent School Districts
- Higher Education Inst. (Public)
- Tribal Governments (Federally Recognized)
- 501(c)(3) Nonprofits
- City/Township Governments
- County Governments
- Non-501(c)(3) Nonprofits
- For Profit Organizations
- Small Businesses
- Special District Governments
- State Governments
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Other
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks applicants for the Atopic Dermatitis Research Network (ADRN) program (U19 Clinical Trial Optional), a cooperative agreement mechanism with an application due date of September 24, 2026. The program supports research centers conducting interdisciplinary and translational research on skin immunology and atopic dermatitis, with emphasis on chronic skin inflammation and skin defense mechanisms.
NIAID will fund Centers that integrate clinical and translational research to improve understanding and management of atopic dermatitis. Research activities include investigating differences between individuals with atopic dermatitis and healthy controls in skin immune responses, structure, and function; conducting single-site pilot trials and observational studies; and providing opportunities for junior investigators to build research background and foster independence.
Eligible applicant categories include higher education institutions (public and private), 501(c)(3) and non-501(c)(3) nonprofits, independent school districts, state and local governments, tribal governments (federally and non-federally recognized), tribal organizations, special district governments, public or Indian housing authorities, for-profit organizations, and small businesses. Foreign organizations and non-U.S. components of U.S. organizations are ineligible. Non-domestic components and foreign collaborations are not permitted.
The program operates under CFDA 93.855 (Allergy and Infectious Diseases Research). Applications are subject to standard NIH scientific merit and programmatic review by initial review groups and the National Advisory Allergy and Infectious Diseases Council, with evaluation criteria encompassing scientific significance, experimental design adequacy, investigator competency, resource availability, budget justification, and relevance to program objectives.
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Files
| File | Type | Posted |
|---|---|---|
| PKG00293498.pdf | ||
| RFA-AI-27-004-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity